Emerging relations between infectious diseases and coronary artery disease and atherosclerosis

I W Fong1

  • 1Department of Medicine, St. Michael's Hospital, Toronto, Ont. fongi@smh.toronto.on.ca

Insights

Infectious diseases, like Chlamydia pneumoniae, may contribute to cardiovascular disease (CVD) in some patients. Further research is needed to confirm causality and guide antibiotic therapy for coronary artery disease (CAD).

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Microbiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality globally.
  • A significant number of coronary artery disease (CAD) patients lack traditional risk factors.
  • Infectious agents are increasingly investigated for their potential role in CVD development and progression.

Purpose of the Study:

  • To review the current evidence linking infectious diseases to coronary artery disease (CAD).
  • To discuss the established association with Chlamydia pneumoniae and controversial links with other pathogens.
  • To explore the implications for future therapeutic strategies in managing cardiovascular disease and stroke.

Main Methods:

  • Literature review of studies investigating the association between infections and CAD.
  • Analysis of data on specific pathogens such as Chlamydia pneumoniae, cytomegalovirus, and Helicobacter pylori.
  • Evaluation of evidence regarding infectious agents in restenosis and post-transplant CAD.

Main Results:

  • A strong association exists between Chlamydia pneumoniae and CAD, though causality is unproven.
  • Cytomegalovirus shows a more significant link to restenosis and post-transplant CAD.
  • Evidence for other infections like Helicobacter pylori and periodontitis remains controversial.

Conclusions:

  • Infections may play a role in the multifactorial nature of cardiovascular disease.
  • Proving causality is crucial before widespread implementation of antibiotic therapy for CAD.
  • Ongoing clinical trials are essential to determine the efficacy of antimicrobial treatments for cardiovascular conditions.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...